RE: Ruck28 May 2020 09:40
Happy birthday Ruck.
To me the problem seems quite clear. The science is good - when 'tested' it has shown itself to be effective through the pre-clinical and clinical work and has shown itself to be credible through the collaborations which it has engendered. The BOD, on the other hand, have not proven themselves to be effective in the critical area of deal making - this is not a criticism of the BOD as I'm sure they have been trying, but results speak for themselves and so far they have shown themselves not to have the capability to achieve this. To criticise the BOD for failing to get a deal would be like criticising a defender for not not regularly scoring - what the BOD need to do is address their now obvious weakness by recruiting somebody with the skill, credibility, experience, industry standing and contacts to fill this deal making gap. Easier said than done but clearly needed. If they can't do a deal now when the opportunity for COVIDITY and the science that underpin it are so good then that says it all for me.